October 4, 2017 — MyoKardia Inc. recently provided a clinical update on its MYK-491 program for dilated...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
News | Pharmaceuticals | October 04, 2017
News | Pharmaceuticals | September 12, 2017
September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in...
News | ESC | September 12, 2017
September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with...
News | ESC | September 12, 2017
September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk...
Feature | Antiplatelet and Anticoagulation Therapies | September 12, 2017
September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with...
News | Pharmaceuticals | September 11, 2017
September 11, 2017 — Merck and researchers in the Clinical Trial Service Unit at the University of Oxford announced...
News | Atrial Fibrillation | September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with...
News | Antiplatelet and Anticoagulation Therapies | August 28, 2017
August 28, 2017 — Bristol-Myers Squibb Company and Pfizer Inc. announced results from an analysis of real-world data...
News | Antiplatelet and Anticoagulation Therapies | August 18, 2017
August 18, 2017 — Medtronic plc announced a global randomized...
News | Antiplatelet and Anticoagulation Therapies | August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI)...
News | Antiplatelet and Anticoagulation Therapies | August 03, 2017
August 3, 2017 — Abbott recently announced the first patient has been enrolled in a...
News | Antiplatelet and Anticoagulation Therapies | July 25, 2017
July 25, 2017 — A study by researchers at the University of Birmingham has shown that general practitioners (GPs)...
News | Point of Care Testing | July 17, 2017 | Dave Fornell
July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is...
News | Antiplatelet and Anticoagulation Therapies | July 12, 2017
June 12, 2017 — Researchers have evaluated the long-term efficacy and safety of long-duration dual anti-platelet...
